Disruption of IGF-1R signaling increases TRAIL-induced apoptosis: A new potential therapy for the treatment of melanoma
- 1 July 2010
- journal article
- Published by Elsevier in Experimental Cell Research
- Vol. 316 (12), 1994-2007
- https://doi.org/10.1016/j.yexcr.2010.04.014
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (ES 11804, P42 ES 10349, CA 49062, P30 ES 09089)
This publication has 55 references indexed in Scilit:
- Deregulated Akt3 Activity Promotes Development of Malignant MelanomaCancer Research, 2004
- Arsenite Sensitizes Human Melanomas to Apoptosis via Tumor Necrosis Factor α-mediated PathwayPublished by Elsevier ,2004
- Recent Advances in Melanoma BiologyThe Oncologist, 2004
- Genetic Interaction Between NRAS and BRAF Mutations and PTEN/MMAC1 Inactivation in MelanomaJournal of Investigative Dermatology, 2004
- Cyclolignans as Inhibitors of the Insulin-Like Growth Factor-1 Receptor and Malignant Cell GrowthCancer Research, 2004
- An anti-insulin-like growth factor I receptor antibody that is a potent inhibitor of cancer cell proliferation.2003
- BRAF as a potential therapeutic target in melanoma and other malignanciesCancer Cell, 2003
- ERK and PI3K negatively regulate STAT-transcriptional activities in human melanoma cells: implications towards sensitization to apoptosisOncogene, 2003
- Death receptors and melanoma resistance to apoptosisOncogene, 2003
- PTEN signaling pathways in melanomaOncogene, 2003